Metabolic Associated Fatty Liver Disease (MAFLD) has emerged as a global public health concern due to its increasing ...

Maternal diet, excess bile acid and liver disease - Moms who eat a high-fat, high-sugar diet during pregnancy can increase ...

The liver is the body’s chemical factory, where most metabolic processes take place. It processes everything you eat and drink, converting them into energy and essential nutrients. Additionally, the ...

Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...

Sleep deprivation leads to increased production of free fatty acids and triglycerides. World Sleep Day special ...

Researchers have found that stellate cells – known for their role in liver fibrosis – play a key role in protecting and ...

THR-beta agonists are the only medication approved to treat metabolic dysfunction–associated steatohepatitis (MASH), a severe ...

Denifanstat Phase 3 MASH program initiated in Q4 2024; patient screening expected to start in 1H 2025 Denifanstat received Breakthrough Therapy designation from FDA for MASH Clearance of Investigation ...

Sagimet Biosciences Inc. (Nasdaq: SGMT), clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today reported financial ...

Shilpa Medicare Limited (BSE: 530549) (NSE: SHILPAMED), a leading API and formulation manufacturer, announces that the Subject Expert Committee (SEC) of CDSCO has approved its Investigational New Drug ...